Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000816309 | SCV000956810 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002534895 | SCV003539128 | uncertain significance | Inborn genetic diseases | 2021-12-07 | criteria provided, single submitter | clinical testing | The c.3856C>T (p.R1286C) alteration is located in exon 20 (coding exon 19) of the COL12A1 gene. This alteration results from a C to T substitution at nucleotide position 3856, causing the arginine (R) at amino acid position 1286 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |